Skip to main content
. 2013 Jun 1;6(3):329–337. doi: 10.1593/tlo.12490

Figure 6.

Figure 6

Biodistribution of gadolinium in the major organs and tissues of mice at 7 days after intravenous administration of ProHance, scrambled Tris-(Gd-DOTA)3, or SBK2-Tris-(Gd-DOTA)3 contrast agents at a dose of 0.1 mmol Gd/kg in nu/nu athymic mice bearing LN-229 flank tumors (n = 3 mice per condition). Data shown as means ± SEM (*P < .05, **P < .001 compared to ProHance).